Cytotoxic T lymphocyte response to peptide vaccination predicts survival in stage III colorectal cancer

We previously reported a phase I clinical trial of a peptide vaccine ring finger protein 43 (RNF43) and 34‐kDa translocase of the outer mitochondrial membrane (TOMM34) combined with uracil‐tegafur (UFT)/LV for patients with metastatic colorectal cancer (CRC), and demonstrated the safety and immunolo...

Descripción completa

Detalles Bibliográficos
Autores principales: Kawamura, Junichiro, Sugiura, Fumiaki, Sukegawa, Yasushi, Yoshioka, Yasumasa, Hida, Jin‐ichi, Hazama, Shoichi, Okuno, Kiyotaka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5980387/
https://www.ncbi.nlm.nih.gov/pubmed/29473265
http://dx.doi.org/10.1111/cas.13547

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5980387/
https://www.ncbi.nlm.nih.gov/pubmed/29473265
http://dx.doi.org/10.1111/cas.13547

Ejemplares similares